DK1401422T3 - Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf - Google Patents

Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf

Info

Publication number
DK1401422T3
DK1401422T3 DK02711967T DK02711967T DK1401422T3 DK 1401422 T3 DK1401422 T3 DK 1401422T3 DK 02711967 T DK02711967 T DK 02711967T DK 02711967 T DK02711967 T DK 02711967T DK 1401422 T3 DK1401422 T3 DK 1401422T3
Authority
DK
Denmark
Prior art keywords
halopohalite
sodium
taurine
halogen
preparation
Prior art date
Application number
DK02711967T
Other languages
Danish (da)
English (en)
Inventor
Arnaud Mainnemare
Original Assignee
Arnaud Mainnemare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arnaud Mainnemare filed Critical Arnaud Mainnemare
Application granted granted Critical
Publication of DK1401422T3 publication Critical patent/DK1401422T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Glass Compositions (AREA)
DK02711967T 2001-01-23 2002-01-16 Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf DK1401422T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0100862A FR2819723B1 (fr) 2001-01-23 2001-01-23 Composition halogene, son procede de preparation et ses utilisations
PCT/FR2002/000151 WO2002058692A2 (fr) 2001-01-23 2002-01-16 Composition halogenee de hypohalites avec n-chloramine taurine, procede de preparation et ses utilisations

Publications (1)

Publication Number Publication Date
DK1401422T3 true DK1401422T3 (da) 2007-08-06

Family

ID=8859119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02711967T DK1401422T3 (da) 2001-01-23 2002-01-16 Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf

Country Status (13)

Country Link
US (3) US20040022871A1 (de)
EP (1) EP1401422B1 (de)
JP (3) JP2004519462A (de)
AT (1) ATE358474T1 (de)
AU (1) AU2002231889A1 (de)
CA (1) CA2435419C (de)
CY (1) CY1106704T1 (de)
DE (1) DE60219314T2 (de)
DK (1) DK1401422T3 (de)
ES (1) ES2284837T3 (de)
FR (1) FR2819723B1 (de)
PT (1) PT1401422E (de)
WO (1) WO2002058692A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2819723B1 (fr) * 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
SE0103766D0 (sv) * 2001-11-09 2001-11-09 Astrazeneca Ab Novel assay
AR039385A1 (es) * 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
CA2535926C (en) 2003-08-18 2012-10-09 Novacal Pharmaceuticals, Inc. N,n-dihalogenated amino acids and derivatives
SE0302756D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel Compounds
SE0402591D0 (sv) * 2004-10-25 2004-10-25 Astrazeneca Ab Novel use
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
US20070244449A1 (en) * 2005-10-06 2007-10-18 Novacal Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including Urinary Tract Infections (UTI) using N-halogenated amino acids
TW200804383A (en) * 2006-06-05 2008-01-16 Astrazeneca Ab New compounds
US20080288019A1 (en) * 2007-01-31 2008-11-20 Adam Heller Electrochemical management of pain
ES2608047T3 (es) * 2008-04-10 2017-04-05 Waldemar Gottardi Composiciones que comprenden amina N-halogenada o N,N-dihalogenada para el tratamiento y profilaxis de infecciones broncopulmonares
WO2009127924A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
US8945540B2 (en) * 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
US9642780B2 (en) 2011-06-15 2017-05-09 Rls Global Ab Detection and removal of carious dentin tissue
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
JP6295274B2 (ja) * 2013-01-30 2018-03-14 ストラウマン ホールディング アーゲー 歯周病の処置
FR3009196B1 (fr) * 2013-08-02 2015-10-02 Arnaud Mainnemare Nouvelle composition pour le traitement de l'inflammation
CA3026576A1 (en) 2016-06-09 2017-12-14 Johnson Matthey Public Limited Company Electrolytic production of organic chloramine solutions
RU2624166C1 (ru) * 2016-07-29 2017-06-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) Способ лечения деструктивных форм хронических верхушечных периодонтитов
LU101842B1 (en) 2020-06-08 2021-12-08 Arnaud Mainnemare Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
IT202000028082A1 (it) 2020-11-23 2022-05-23 Md Italy Srl Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012842A (en) * 1972-06-12 1977-03-22 National Patent Development Corporation Dental treatment method and apparatus
CA1025705A (en) 1972-06-12 1978-02-07 Jaroslav Vit Method and apparatus for removal of dental plaque and caries by means of high velocity pulsating jet of liquid
US3998945A (en) * 1972-06-12 1976-12-21 National Patent Development Corporation Dental treatment
US4035483A (en) * 1973-05-29 1977-07-12 John Bunyan Antiseptic and non-toxic substance and a method of making the same
DE4041703C2 (de) * 1990-12-24 1993-10-21 Waldemar Dr Gottardi Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung
JP3759757B2 (ja) * 1994-01-13 2006-03-29 相互薬工株式会社 殺菌剤
DE19712565A1 (de) * 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
JPH11279057A (ja) 1998-03-30 1999-10-12 Arimasa Miyamoto ＮＦκＢ活性化阻害剤
DE19816102C1 (de) * 1998-04-10 1999-09-16 Waldemar Gottardi Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen
DE60037657T2 (de) * 1999-06-04 2009-01-08 Oxibio, Inc., Portland Infektionsmittel enthaltendes medizinisches gerät und verfahren zu ihrer darstellung
FR2819723B1 (fr) * 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
JP4948846B2 (ja) 2006-02-08 2012-06-06 株式会社東芝 突入電流抑制回路を備えた電源装置

Also Published As

Publication number Publication date
EP1401422B1 (de) 2007-04-04
ES2284837T3 (es) 2007-11-16
DE60219314T2 (de) 2008-01-03
ATE358474T1 (de) 2007-04-15
PT1401422E (pt) 2007-07-09
JP2004519462A (ja) 2004-07-02
WO2002058692A2 (fr) 2002-08-01
WO2002058692A9 (fr) 2003-03-06
US20040022871A1 (en) 2004-02-05
US8709498B2 (en) 2014-04-29
US20110091578A1 (en) 2011-04-21
JP2013189477A (ja) 2013-09-26
FR2819723A1 (fr) 2002-07-26
CA2435419C (fr) 2012-06-05
WO2002058692A3 (fr) 2003-12-24
JP2010174050A (ja) 2010-08-12
US20090022815A1 (en) 2009-01-22
FR2819723B1 (fr) 2006-11-17
US7879366B2 (en) 2011-02-01
CY1106704T1 (el) 2012-05-23
DE60219314D1 (de) 2007-05-16
AU2002231889A1 (en) 2002-08-06
CA2435419A1 (fr) 2002-08-01
EP1401422A2 (de) 2004-03-31

Similar Documents

Publication Publication Date Title
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
DK1898876T3 (da) Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former
ES2091737T3 (es) Formulaciones farmaceuticas de fluoxetina.
NO20061489L (no) Formuleringer og fremgangsmater for a behandle inflamatorisk tarmsykdom
HUP0301452A2 (hu) Fotokemoterápiás szert és mukoadhéziós szert tartalmazó gyógyszerkészítmény és alkalmazása
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
TR200200716T2 (tr) Ketiyapin granülleri
NO994431L (no) Ny formulering
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
NO20051261L (no) Morfin-6-glukuronidsalt
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
BR9814867A (pt) Método para tratar discinesias relacionadas a doenças ou induzidas por drogas
ATE353011T1 (de) Zusammensetzung zur behandlung von gastrointestinalen beschwerden
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
RU2000108520A (ru) Способ восстановительного лечения больных остеоартрозом
ES2185147T3 (es) Nuevos usos medicos del orosomucoide.
BR0314647A (pt) Uso de derivados de 4-piridilmetil-ftalazina para a preparação de um medicamento para o tratamento de sìndromes melodisplásicas
RU2003128374A (ru) Способ лечения лучевых эпителиитов